Coronary CT Angiography-Guided vs. IVUS-Guided PCI: The Randomized P4 Trial

Carlos Collet

Sirolimus Coated Balloons vs. Drug-eluting Stents in Native Coronary Vessels: The TRANSFORM II Randomized Trial

Bernardo Cortese

A Randomized Trial of Higher vs. Lower Dose Heparin for PCI: The HD-PCI Trial

Sanjit Jolly

Coronary Sinus Reducer for Refractory Angina in ANOCA: A Randomized Double-Blind Sham-Controlled Trial (REMEDY-PILOT)

Kevin Cheng

TAVR or Clinical Surveillance for Moderate Aortic Stenosis: Primary Results of the PROGRESS Randomized Trial

Philippe Genereux

Transcatheter Tricuspid Valve Repair with the PASCAL System vs. Medical Therapy for Severe, Symptomatic Tricuspid Regurgitation: Clinical and Health Status Outcomes from the CLASP II TR Randomized Trial

Charles Davidson
Suzanne Arnold

Global Burden and Outcomes of Degenerative Mitral Valve Disease: A 30-Year Analysis of the Global Burden of Disease Study

Juan F. Granada

Antithrombotic Monotherapy After Left Atrial Appendage Occlusion: Primary Results of the SIMPLAAFY Randomized Trial

Saibal Kar

Angiography-Derived FFR vs. Usual Care for Lesion Selection and Optimization in All-Comers PCI: Final Results of the PIONEER IV Randomized Trial

Patrick Serruys

Platelet Function Testing to Guide P2Y12 Inhibitor De-Escalation After ACS: The EPIC17-VERONICA Randomized Trial

Iñigo Lozano

Safety and Effectiveness of Radiofrequency Renal Denervation in the United States: Primary Results of the SPYRAL AFFIRM Post-Approval Study

David Kandzari

Single vs. Double ProGlide Devices for Access Site Closure After Transfemoral TAVR: The SINGLE-CLOSURE Trial

Jian'an Wang

The ProtEmbo^® Cerebral Protection System During TAVR: Final Results of the Randomized PROTEMBO IDE Trial

Susheel Kodali

Characteristics and Clinical Outcomes of Tricuspid Regurgitation in the Community: Insights from a Real-World Cohort of 180,977 Men and Women

Rebecca Hahn

Transcatheter Tricuspid Valve Replacement with the LuX-Valve Plus System vs. Medical Therapy for Severe TR: The Randomized TRAVEL III Trial

Junbo Ge

Transcatheter Tricuspid Valve Intervention in Heart Failure: Key Subgroup Results from the TRIC-I-HF-DZHK24 Trial

Jörg Hausleiter

One-Year Outcomes with the Amulet 360 Device for Left Atrial Appendage Closure: The VERITAS Amulet 360 Study

Dhanunjaya Lakkireddy

Left Atrial Appendage Closure vs. Contemporary Medical Therapy for Stroke Prevention in AF (LANTERN): An IPD Meta-Analysis of Randomized Trials

Rohin Reddy

One-Year Outcomes of the PeriSorb Bioresorbable Vascular Scaffold vs. Drug-Coated Balloon for Superficial Femoral Artery Disease: A Multicenter Randomized Trial

Yuan Che

Three-Year Outcomes of Sirolimus vs. Paclitaxel-Coated Balloons for Femoropopliteal Artery Disease: The Randomized SIRONA Trial

Ulf Teichgräber

Impact of Non-Culprit Lesion Severity on the Utility of Functional Coronary Angiography in Patients with STEMI and Multivessel Disease: The AIR STEMI Randomized Trial

Simone Biscaglia

Angiography-Derived FFR Versus vs. Wire-Based FFR to Guide Coronary Revascularization: The LIPSIA-STRATEGY Trial

Nicolas Majunke

Intracoronary Delivery of Nicorandil for Prevention of No-Reflow Patients Undergoing Primary PCI for STEMI: A Multicenter Randomized Trial

Takashi Muramatsu

Transcatheter vs. Surgical AVR for Symptomatic, Severe Aortic Regurgitation: One-Year Outcomes from a Multicenter Randomized Trial

Xiaoping Peng

Transcatheter Aortic Valve Replacement with the JenaValve Trilogy System for Aortic Regurgitation in Patients with a Left Ventricular Assist Device: The JENA-VAD Study

Ravi Ramana

Economic Outcomes and Cost-Effectiveness of TAVR for Asymptomatic Severe Aortic Stenosis: Results from the EARLY TAVR Trial

Neel Butala

Routine Post-Dilation vs. Conventional Deployment for Balloon-Expandable TAVR: The Randomized DUOTAP Trial

Maximilian Autherith

Percutaneous Transcatheter Mitral Valve Replacement in Patients with Symptomatic Mitral Regurgitation: 2-Year Outcomes from the ENCIRCLE Trial

John G. Webb